Full-Time

Clinical Trial Assistant II

Clinical Operations

Confirmed live in the last 24 hours

Revolution Medicines

Revolution Medicines

501-1,000 employees

Develops targeted therapies for RAS-driven cancers

Biotechnology
Healthcare

Compensation Overview

$75k - $90kAnnually

Junior, Mid

San Carlos, CA, USA

Hybrid position requiring some in-office days.

Category
Healthcare Administration & Support
Medical, Clinical & Veterinary
Required Skills
Word/Pages/Docs
Excel/Numbers/Sheets

You match the following Revolution Medicines's candidate preferences

Employers are more likely to interview you if you match these preferences:

Degree
Experience
Requirements
  • Bachelor’s degree in biological sciences or related health related field required.
  • 1 - 3 years of relevant experience in the pharmaceutical or biotech industry, preferably in clinical operations or clinical research-related experience.
  • Excellent written and verbal communication skills.
  • Demonstrate proficiency in Microsoft Word, Excel and PowerPoint and other software platforms.
  • Demonstrated ability to multi-task, prioritize options.
  • Travel up to (~25%).
Responsibilities
  • Assisting in the development, review, distributing, and archiving of study specific documents and reports (plans, training materials, study guides, manuals, etc.)
  • Assisting with updating and maintaining clinical systems and any reporting tools.
  • Set up and maintenance of the trial master files (TMF) if applicable, or work with CRO to audit and resolve discrepancies.
  • Create, maintain, and track information for key study related activities.
  • Assisting in the preparation of meeting materials, scheduling meetings, and developing agendas, taking meeting minutes for internal clinical operation team meetings.
  • Gathering investigator and site information, to support study start-up, maintenance and close out activities.
  • Working with cross functional study teams, and vendors to assist in the coordination of clinical trial activities.
  • Support other clinical operations activities as appropriate.
Desired Qualifications
  • Preferably in clinical operations or clinical research-related experience.
  • Experience in oncology clinical trials.

Revolution Medicines develops treatments specifically for cancers caused by RAS gene mutations, which are common in difficult-to-treat cancers like pancreatic, colorectal, and lung cancers. Their main product line includes RASON Inhibitors, designed to target and inhibit RAS proteins that contribute to cancer growth. The company uses a Tri Complex Inhibitor platform to create these specialized therapies. Unlike many competitors, Revolution Medicines focuses solely on RAS-driven cancers, allowing them to carve out a niche in the oncology market. Their goal is to transform cancer treatment by providing effective targeted therapies for patients suffering from these challenging conditions.

Company Stage

IPO

Total Funding

$219.8M

Headquarters

Redwood City, California

Founded

2014

Growth & Insights
Headcount

6 month growth

-2%

1 year growth

-2%

2 year growth

7%
Simplify Jobs

Simplify's Take

What believers are saying

  • Acquisition of EQRx adds over $1 billion in capital for R&D.
  • FDA fast-tracking supports their RAS-targeted therapy pipeline.
  • Growing interest in targeted cancer therapies boosts investment opportunities.

What critics are saying

  • EQRx acquisition may pose integration challenges and cultural clashes.
  • $600M public stock offering could lead to shareholder dilution.
  • Focus on RAS-addicted cancers limits market scope and increases competition risk.

What makes Revolution Medicines unique

  • Revolution Medicines reconfigures natural substances into best-in-class cancer therapies.
  • Their Tri Complex Inhibitor platform targets RAS proteins driving cancer growth.
  • Exclusive license with University of Illinois enhances their unique synthesis technology.

Help us improve and share your feedback! Did you find this helpful?

Benefits

Company Equity